About Eskag Pharma
Eskag Pharma is a Healthcare company based in Kolkata (India) founded in 1972 by Anup Bannerjee. It manufactures and supplies pharmaceutical products for therapeutic areas like dermatology and gastroenterology. It operates on a B2B and Manufacturing model. The company has 594 employees. Its chief executive is Anup Bannerjee. Its Indian entity Eskag Pharma Pvt Ltd reported revenue of ₹82.92 Cr. Eskag Pharma offers products and services including Relux L, Tribs, Tinicline, FeCM Injection, and Relux 100ml. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutics and Nutraceuticals. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Eskag Pharma Pvt. Ltd. is a leading pharmaceutical manufacturer in India, producing high-quality medications for various therapeutic areas including gastroenterology, pediatrics, and gynaecology. They operate through research-driven formulations and third-party manufacturing, exporting to over 20 countries. Based in Kolkata and Haridwar, they prioritize innovation, quality control, and global supply chains to serve healthcare professionals and distributors effectively.
- Annual Revenue₹82.92 Cr
FY 2025 · +8% YoY
- Net Profit₹8.34 Cr
FY 2025 · 10% margin
- EBITDA₹17.83 Cr
FY 2025 · 22% margin
- Employee Count594
Associated legal entities of Eskag Pharma
Eskag Pharma is associated with 3 registered companies on The Company Check; the primary company is Eskag Pharma Pvt Ltd. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eskag Pharma Pvt Ltd CIN U24234WB1977PTC030897 | Active | 24 Feb 1977 | Kolkata, West Bengal | ₹82.9 Cr | 594 | 2 | View details |
| Upashaya Healthcare Llp CIN ABZ-2077 | Active | 25 Nov 2022 | North 24 Parganas, West Bengal | – | – | 3 | View details |
| Samhwa Paints India Private Limited CIN U24233UP2016PTC075804 | Active | 15 Jan 2016 | Noida, Uttar Pradesh | ₹95.0 Cr | 41 | 3 | View details |
Products & Services of Eskag Pharma
Eskag Pharma offers a comprehensive portfolio of products and services, including Relux L, Tribs, Tinicline, FeCM Injection, and Relux 100ml.
Oral laxative for constipation relief and digestive health support.
Tablets for managing gynaecological conditions effectively.
Medication combining antibiotics for infection treatment.
Iron replenishment formulation for rapid health restoration.
Polyethylene glycol liquid for pediatric laxative use.
Apps and channels of Eskag Pharma
its YouTube channel Eskag Pharma Pvt. Ltd. has 66 subscribers and 10 videos.
Videos from Eskag Pharma
The most watched videos on Eskag Pharma's YouTube channel, Eskag Pharma Pvt. Ltd. (66 subscribers). Click a video to play it here.
More on Eskag Pharma Pvt. Ltd..
Board of directors of Eskag Pharma Pvt Ltd (Eskag Pharma)
Eskag Pharma Pvt Ltd is the primary company behind Eskag Pharma. The boards of the 3 registered companies of Eskag Pharma currently have 7 directors; the longest-serving is Sunil Kumar Agarwal, appointed in 1984. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunil Kumar Agarwal DIN 00828184 | Director | 13 Jun 1984 | 42 yrs 4 mo | Eskag Pharma Pvt Ltd |
| Jeong Bae Kim DIN 07920853 | Director | 27 Aug 2017 | 9 yrs 1 mo | Samhwa Paints India Private Limited |
| Giman Kim DIN 09728279 | Director | 10 Sep 2022 | 4 yrs 1 mo | Samhwa Paints India Private Limited |
| Sashreek Agarwal DIN 10030330 | Designated Partner | 25 Nov 2022 | 3 yrs 10 mo | Upashaya Healthcare Llp |
| Shobhana Agarwal DIN 10030329 | Designated Partner | 25 Nov 2022 | 3 yrs 10 mo | Upashaya Healthcare Llp |
| Sungcheul Cho DIN 10242550 | Managing Director | 20 Jul 2023 | 3 yrs 2 mo | Samhwa Paints India Private Limited |
| Anil Kumar Agarwal DIN 00637461 | Designated Partner | 08 Mar 2025 | 1 yr 7 mo | Upashaya Healthcare Llp, Eskag Pharma Pvt Ltd |
People of Eskag Pharma
1 people are tracked at Eskag Pharma (1 in leadership); the tracked headcount is 594.
| Name | Role | Group |
|---|---|---|
Anup Bannerjee | Founder, CEO | Leadership |
Complete people profiles for Eskag Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Eskag Pharma
Figures of Eskag Pharma Pvt Ltd, the primary company behind Eskag Pharma, for FY 2025. Revenue was ₹82.92 Cr (+8% year on year). Net profit was ₹8.34 Cr (10% margin). EBITDA was ₹17.83 Cr (22% margin). Revenue has grown at a compounded annual rate of +7% over three years.
- ₹82.92 CrRevenue · FY 2025 · +8% YoY
- ₹8.34 CrNet profit · 10% margin
- ₹17.83 CrEBITDA · 22% margin
- ₹1.68 CrPaid-up capital
- 594Employees (provident fund records)
- +7%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Eskag Pharma Pvt Ltd are on its company page.
Detailed financial statements for Eskag Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Eskag Pharma
Eskag Pharma has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Eskag Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Eskag Pharma
Websites that share an audience with Eskag Pharma (eskag.in).
Websites whose visitors overlap most with Eskag Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| macrolabs.in | 94% | 4.4K | #4,690,758 | View details | |
| medicefpharma.com | 88% | 4.1K | #3,949,515 | View details | |
| savaglobal.com | 28% | 6K | #4,334,220 | View details | |
| centurypharma.com | 24% | 2.1K | #6,652,065 | View details | |
| francoindian.com | 24% | 2.9K | #1,977,293 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Eskag Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eskag Pharma
Eskag Pharma was founded in 1972.
Eskag Pharma is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Anup Bannerjee is the current CEO of Eskag Pharma. They have also founded this company.
Eskag Pharma has 594 employees.
The primary company behind Eskag Pharma, Eskag Pharma Pvt Ltd, reported revenue of ₹82.92 Cr for FY 2025, up 8% year on year.
Eskag Pharma Pvt. Ltd. is a leading pharmaceutical manufacturer in India, producing high-quality medications for various therapeutic areas including gastroenterology, pediatrics, and gynaecology. They operate through research-driven formulations and third-party manufacturing, exporting to over 20 countries. Based in Kolkata and Haridwar, they prioritize innovation, quality control, and global supply chains to serve healthcare professionals and distributors effectively.
Eskag Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Eskag Pharma offers Relux L, Tribs, Tinicline, FeCM Injection, and Relux 100ml.
Eskag Pharma is associated with 3 legal entities: Eskag Pharma Pvt Ltd, Upashaya Healthcare Llp, Samhwa Paints India Private Limited.
The legal entities of Eskag Pharma currently have 7 directors, including Anil Kumar Agarwal, Sashreek Agarwal, Shobhana Agarwal and others.